Recently, a publication provided a novel sight for breast cancer treatment that KPNA2 and IL-6 associated inflammation could facilitate c-Myc nuclear translocation and regulate breast cancer development [41], and this similar mechanism has also been verified in our prostatic cancer cells. This evidence concerns the gene KPNA2 and prostate cancer.